GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantech Holding Inc (OTCPK:BSSP) » Definitions » Inventories, Raw Materials & Components

Cantech Holding (Cantech Holding) Inventories, Raw Materials & Components : $0.00 Mil (As of Sep. 2015)


View and export this data going back to 2011. Start your Free Trial

What is Cantech Holding Inventories, Raw Materials & Components?

Cantech Holding's inventories, raw materials & components for the quarter that ended in Sep. 2015 was $0.00 Mil.


Cantech Holding Inventories, Raw Materials & Components Historical Data

The historical data trend for Cantech Holding's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantech Holding Inventories, Raw Materials & Components Chart

Cantech Holding Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Inventories, Raw Materials & Components
- - - -

Cantech Holding Quarterly Data
Sep10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cantech Holding Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Cantech Holding (Cantech Holding) Business Description

Industry
Traded in Other Exchanges
N/A
Address
120 W Pomona Avenue, Monrovia, CA, USA, 91016
Cantech Holding Inc is a development stage immunotherapeutic-based technology company. Principally, it is focused on commercialization of its proprietary proteins for the treatment of cancer and various infectious diseases. Its Irreversible Pepsine Fraction (IPF) is a therapeutic platform technology that can be used to facilitate varieties of applications. The company's product consists of IMMUNE-THERAPEUTIC PROTEIN which is a therapeutic protein isolated from porsine pepsin and is irreversible, modified, and fractionated to the sequence IPF.
Executives
Pamela Elliott officer: Secretary and Treasurer 1960 GRAEAGLE LANE, LINCOLN CA 95648